首页> 外文期刊>Journal of chromatography, A: Including electrophoresis and other separation methods >Chromatography-based methods for determining molar extinction coefficients of cytotoxic payload drugs and drug antibody ratios of antibody drug conjugates
【24h】

Chromatography-based methods for determining molar extinction coefficients of cytotoxic payload drugs and drug antibody ratios of antibody drug conjugates

机译:基于色谱的方法确定细胞毒性有效载荷药物的摩尔消光系数和抗体药物偶联物的药物抗体比率

获取原文
获取原文并翻译 | 示例
           

摘要

UV spectrophotometry is widely used to determine the molar extinction coefficients (MECs) of cytotoxic drugs as well as the drug antibody ratios (DARs) of antibody drug conjugates (ADCs). However, the unknown purity of a drug due to interfering impurities can lead to erroneous MECs and DARs. Hence, reliable methods to accurately determine purity and the MECs of drugs with limited quantity is urgently needed in Drug Discovery. Such a method has been developed. It achieves absolute purity and accurate MEC determination by a single automated HPLC analysis that uses less than 5 mu g of material. Specifically, analytical HPLC separation with online UV detection was used to resolve impurities and measure absorbance from only the compound of interest. Simultaneously, an online chemiluminescence nitrogen detector (CLND) was used to determine the concentration of the analyte. The MECs were then calculated from the absorbance and concentration results. The accuracy of the method was demonstrated using caffeine and a commercial cytotoxic drug, DM1. This approach is particularly suited to analyzing mixtures or samples with low purities. Excellent reproducibility was demonstrated by analyzing a proprietary drug with linker synthesized from different batches with very different levels of purity. In addition, the MECs of drug with linker, along with ADC peak areas measured from size exclusion chromatography (SEC), were used to calculate DARs for 21 in-house ADCs. The DAR results were consistent with those obtained by MS analysis. (C) 2016 Elsevier B.V. All rights reserved.
机译:紫外分光光度法广泛用于确定细胞毒性药物的摩尔消光系数(MEC)以及抗体药物结合物(ADC)的药物抗体比率(DAR)。但是,由于杂质干扰而导致的未知纯度的药物会导致错误的MEC和DAR。因此,在药物发现中迫切需要可靠的方法来准确确定数量有限的药物的纯度和MEC。已经开发了这种方法。通过使用少于5μg的材料进行的一次自动HPLC分析,可实现绝对纯度和准确的MEC测定。具体而言,使用在线UV检测进行分析型HPLC分离可分离杂质并仅从目标化合物中测量吸光度。同时,使用在线化学发光氮检测器(CLND)确定分析物的浓度。然后根据吸光度和浓度结果计算出MEC。使用咖啡因和商业细胞毒性药物DM1证明了该方法的准确性。该方法特别适合分析低纯度的混合物或样品。通过使用从不同批次合成的具有不同纯度水平的接头分析专利药物,证明了优异的重现性。此外,带有接头的药物的MEC以及通过尺寸排阻色谱法(SEC)测量的ADC峰面积被用于计算21个内部ADC的DAR。 DAR结果与通过MS分析获得的结果一致。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号